REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $259,000 | -37.4% | 10,280 | -34.5% | 0.03% | -43.5% |
Q4 2021 | $414,000 | +77.7% | 15,700 | +579.7% | 0.05% | +64.3% |
Q3 2021 | $233,000 | -59.1% | 2,310 | -59.6% | 0.03% | -56.2% |
Q1 2021 | $570,000 | +125.3% | 5,713 | +252.9% | 0.06% | +68.4% |
Q2 2020 | $253,000 | -28.1% | 1,619 | -6.0% | 0.04% | -32.1% |
Q4 2019 | $352,000 | +46.1% | 1,722 | -42.6% | 0.06% | +33.3% |
Q3 2019 | $241,000 | -20.2% | 3,000 | -15.0% | 0.04% | -16.0% |
Q1 2019 | $302,000 | +39.8% | 3,531 | -64.4% | 0.05% | -13.8% |
Q4 2016 | $216,000 | – | 9,908 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |